ANDREW BUTTON: Open Payments
NPI 1598705428 · NORMAL, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$508 in 45 payments from 10 companies in 2025. Trend: 2023 $283 · 2024 $573 · 2025 $508
Food & beverage: $508
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 30 | $155 |
| CVRx, Inc. | 1 | $92 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $61 |
| Novo Nordisk Inc | 2 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Amgen Inc. | 2 | $35 |
| Abbott Laboratories | 1 | $24 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $17 |
Products named: LEQVIO, Barostim Neo System, LifeVest, Wegovy, REPATHA, ENTRESTO, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, WAINUA.
Industry payments across IL — which companies pay providers there.
